HCM
HUTCHMED (China)DNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
Current thesis
Composite grade D from latest DB weights. Momentum 35.6 / Value 44.1
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
36
Value
44
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-11 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $23.38
Why
Momentum36 · Δ7d -
Value44 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
36
52% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
44
48% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 35.6 / Value 44.1
Fundamentals (TTM)As of 2026-06-11
Fundamentals (TTM)
As of 2026-06-11
Market Cap
$1.9B
Beta
1.25
Shares Out
872.33M
P/E (TTM)
5.1
P/S (TTM)
3.94
P/FCF (TTM) · Derived
-31.77
Rev YoY
-9.2%
EPS YoY
+1663.3%
Gross Margin
+44.2%
Op Margin
-3.3%
Net Debt
-$746.29M
Current Ratio
4.65
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology